Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M MacLeod

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of Clinical Pharmacology|November 1, 1986
Protein-bound homocyst(e)ine in patients with rheumatoid arthritis undergoing D-penicillamine treatmentS S Kang, P W Wong, P B Glickman, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1984
Effects of cirrhosis on kinetics of aztreonamC M MacLeod, E A Bartley, J A Payne, et al.
Neurology|May 1, 1993
Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exerciseC G Goetz, J A Thelen, C M MacLeod, et al.
Biopharmaceutics & Drug Disposition|May 1, 1989
Single oral dose proportionality pharmacokinetics of almitrine bismesylate in humansS Stavchansky, J T Doluisio, C M Macleod, et al.
Biopharmaceutics & Drug Disposition|May 1, 1989
Relative bioavailability of almitrine bismesylate in humansS Stavchansky, J T Doluisio, C M Macleod, et al.
Biopharmaceutics & Drug Disposition|May 1, 1989
One year administration of almitrine bismesylate (Vectarion) to chronic obstructive pulmonary disease patients: pharmacokinetic analysisS Stavchansky, J T Doluisio, C M Macleod, et al.
Scottish Medical Journal|December 1, 1995
Psychosis and substance abuse: cause, effect or coincidence?S M Lawrie, J K Hutchison, S R Sweeney, et al.
Clinical Pharmacology and Therapeutics|May 1, 1990
Diurnal blood pressure in patients with mild-to-moderate hypertension treated with once-daily benazepril hydrochlorideM H Weinberger, H R Black, K C Lasseter, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Clinical Pharmacology|November 1, 1986
Protein-bound homocyst(e)ine in patients with rheumatoid arthritis undergoing D-penicillamine treatmentS S Kang, P W Wong, P B Glickman, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1984
Effects of cirrhosis on kinetics of aztreonamC M MacLeod, E A Bartley, J A Payne, et al.
Neurology|May 1, 1993
Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exerciseC G Goetz, J A Thelen, C M MacLeod, et al.
Biopharmaceutics & Drug Disposition|May 1, 1989
Single oral dose proportionality pharmacokinetics of almitrine bismesylate in humansS Stavchansky, J T Doluisio, C M Macleod, et al.
Biopharmaceutics & Drug Disposition|May 1, 1989
Relative bioavailability of almitrine bismesylate in humansS Stavchansky, J T Doluisio, C M Macleod, et al.
Biopharmaceutics & Drug Disposition|May 1, 1989
One year administration of almitrine bismesylate (Vectarion) to chronic obstructive pulmonary disease patients: pharmacokinetic analysisS Stavchansky, J T Doluisio, C M Macleod, et al.
Scottish Medical Journal|December 1, 1995
Psychosis and substance abuse: cause, effect or coincidence?S M Lawrie, J K Hutchison, S R Sweeney, et al.
Clinical Pharmacology and Therapeutics|May 1, 1990
Diurnal blood pressure in patients with mild-to-moderate hypertension treated with once-daily benazepril hydrochlorideM H Weinberger, H R Black, K C Lasseter, et al.
Pageof 7